AbbVie
ABBV
#31
Rank
ยฃ247.29 B
Marketcap
ยฃ139.94
Share price
0.61%
Change (1 day)
7.46%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of September 2024 : ยฃ57.62 Billion

According to AbbVie's latest financial reports the company's total debt is ยฃ57.62 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31ยฃ46.61 B-10.87%
2022-12-31ยฃ52.29 B-7.94%
2021-12-31ยฃ56.80 B-10.02%
2020-12-31ยฃ63.13 B24.07%
2019-12-31ยฃ50.88 B60.24%
2018-12-31ยฃ31.75 B14.85%
2017-12-31ยฃ27.64 B-7.4%
2016-12-31ยฃ29.85 B39.71%
2015-12-31ยฃ21.37 B122.16%
2014-12-31ยฃ9.61 B7.78%
2013-12-31ยฃ8.92 B-7.95%
2012-12-31ยฃ9.69 B31297.55%
2011-12-31ยฃ30.88 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ยฃ54.00 B-6.28%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ41.67 B-27.69%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ25.22 B-56.22%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ48.96 B-15.03%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ18.84 B-67.29%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.39 B-90.64%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ17.42 B-69.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ25.58 B-55.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ0.20 B-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA